TriPhos Therapeutics, Inc.

Platform-based systemic silencing of aberrantly expressed Human genes to reduce Inflammation, TBI and Opioid Dependence.

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded December 2011
  • Employees 2
  • Incorporation Type C-corp
  • Website http:\\triphosthera.com

Company Summary

Triphos Therapeutics, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of systemic RNAi Delivery Technologies. The Company strives to rapidly advance short interfering RNA (siRNA) platform delivery technologies to advance its own therapeutic programs and to form strategic partnerships with key RNAi therapeutic companies to target a wide variety of acute, chronic and infectious human diseases.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free